Zinc Finger CCCH Domain-Containing Protein 15 (ZC3H15) as A Potential Drug Target Or Biomarker for Cancer

Target Name: ZC3H15

NCBI ID: G55854

ZC3H15

Zinc Finger CCCH Domain-Containing Protein 15 (ZC3H15) as A Potential Drug Target Or Biomarker for Cancer

Zinc finger CCCH domain-containing protein 15 (ZC3H15) is a protein that is expressed in various tissues and organs, including brain, heart, and skeletal muscles. It is characterized by the presence of a zinc finger domain, which is a common structural motif that is involved in protein-protein interactions and is known to play a role in the regulation of cellular processes. ZC3H15 is also known for its ability to interact with other proteins, including the transcription factor p53.

The ZC3H15 gene is located on chromosome 16 and has been implicated in the development and progression of several diseases, including cancer. Several studies have suggested that ZC3H15 may be a potential drug target or biomarker for these diseases.

One potential mechanism by which ZC3H15 may be involved in the development of cancer is its role in cell signaling. ZC3H15 has been shown to play a role in the regulation of cell growth and differentiation, and it is possible that it may be involved in the regulation of cell proliferation. Additionally, ZC3H15 has been shown to interact with the transcription factor p53, which is a key regulator of DNA replication and repair. This suggests that ZC3H15 may be involved in the regulation of p53 function and that this regulation could be a potential target for cancer therapies.

Another potential mechanism by which ZC3H15 may be involved in the development of cancer is its role in cell survival. ZC3H15 has been shown to play a role in the regulation of cell survival and has been shown to interact with the protein Bcl-2. Bcl-2 is a protein that has been shown to play a role in cell survival and has been implicated in the development of many cancers. ZC3H15 may be involved in the regulation of Bcl-2 function, which could make it a potential target for cancer therapies.

In addition to its potential role in cell signaling and survival, ZC3H15 has also been suggested as a potential biomarker for cancer. ZC3H15 has been shown to be expressed in various tissues and organs, including cancer cells, and it has been suggested that it may be a useful biomarker for the diagnosis or monitoring of cancer. Additionally, ZC3H15 has been shown to interact with the protein PDGF-BB, which is a growth factor that has been shown to play a role in the development of cancer. This suggests that ZC3H15 may be involved in the regulation of PDGF-BB function, which could make it a potential target for cancer therapies.

Overall, ZC3H15 is a protein that has been shown to play a role in several cellular processes and has been implicated in the development and progression of several diseases, including cancer. Its unique structure and function may make it a potential drug target or biomarker for these diseases. Further research is needed to fully understand the role of ZC3H15 in cell signaling and survival, as well as its potential as a biomarker for cancer.

Protein Name: Zinc Finger CCCH-type Containing 15

Functions: Protects DRG1 from proteolytic degradation (PubMed:19819225). Stimulates DRG1 GTPase activity likely by increasing the affinity for the potassium ions (PubMed:23711155)

The "ZC3H15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZC3H15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets